Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2005
08/04/2005WO2005070088A2 Chimeric sequences for tissue-specific gene expression in plants
08/04/2005WO2005070066A2 Chlorophyllous totipotent cell cultures
08/04/2005WO2005070044A2 Systems and methods for short rna expression
08/04/2005WO2005070023A2 Expression of apoa-1 and variants thereof using spliceosome mediated rna trans-splicing
08/04/2005WO2005069987A2 Amplifying interfering rna (rnai) expression and effects
08/04/2005WO2005069986A2 Chimeric promoters for use in plants
08/04/2005WO2005069970A2 Antibody specificity transfer using minimal essential binding determinants
08/04/2005WO2005069969A2 Mutant sodium channel nav1.7 and methods related thereto
08/04/2005WO2005069913A2 Expression of mammalian proteins in pseudomonas fluorescens
08/04/2005WO2005069880A2 Modulation of line-1 reverse transcriptase
08/04/2005WO2005069845A2 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
08/04/2005WO2005069744A2 A simple low cost method and product for screening transgenic and non-transgenic plants from a large population either in field or green house
08/04/2005WO2005059131A3 Protein binding miniature proteins and uses thereof
08/04/2005WO2005056020A3 Nf-kb oligonucleotide decoy molecules
08/04/2005WO2005054481A3 Controlling gene expression in plastids
08/04/2005WO2005049793A3 Methods and compositions for combinatorial approaches to cancer gene therapy
08/04/2005WO2005041750A3 Method for identifying compounds that affect expression of tryptophan hydroxylase isoform 2
08/04/2005WO2005037863A3 Alternative splicing factors polynucleotides, polypeptides and uses thereof
08/04/2005WO2005035715A8 Flanking dna sequences that control expression in the human genome
08/04/2005WO2005033318A3 Methods for enhancing stress tolerance in plants and methods thereof
08/04/2005WO2005026342A9 Methods of modulating bone growth, bone remodeling and adiposity
08/04/2005WO2005024040A3 Target and method for inhibition of bacterial rna polymerase: minimized derivatives of peptide antibiotic mccj25
08/04/2005WO2005023994A3 Modified oligonucleotides for telomerase inhibition
08/04/2005WO2005003350A3 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER’S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/04/2005WO2005001045A3 Materials and methods for production of fruit-free, pollen-free plants with large showy flowers
08/04/2005WO2004098533A3 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
08/04/2005WO2004078953A9 Translocating enzyme used as a selection marker
08/04/2005WO2004064782A3 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
08/04/2005WO2004046324A3 Allele-targeted rna interference
08/04/2005WO2004031413A9 Method for diagnosing non-small cell lung cancers
08/04/2005WO2004030750A8 Antisense modulation of farnesoid x receptor expression
08/04/2005WO2004016726A9 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
08/04/2005WO2004003169A3 Recombinant genes for polyketide modifying enzymes
08/04/2005WO2003064589A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/04/2005WO2003062173A3 Alanine 2,3- aminomutase
08/04/2005WO2003000009A3 Stimulation of vascularization with vegf-b
08/04/2005US20050172365 Recombination systems and methods for eliminating nucleic acid sequences from the genome of eukaryotic organisms
08/04/2005US20050172364 Genes for modifying plant traits XI
08/04/2005US20050172363 Nematode PPPT-like sequences
08/04/2005US20050172361 Using antisense RNA to inhibit transcription of preferential gene in plant systems
08/04/2005US20050172359 Using expression vector comprising phaseolin promoter to transfer and express plasma lipoprotein in seeds
08/04/2005US20050172358 Enhanced resistance to plant parasitic nematodes
08/04/2005US20050172357 Insect viruses and their uses in protecting plants
08/04/2005US20050172356 Expression vector comprising nucleotide sequences coding chimeric insecticidal/vacuole targeting protein for use in biological pest control; insect resistance in crop plants
08/04/2005US20050172354 Expression vector comprising nucleotide sequences coding isoflavone 3'-hydroxylase; for identifying modulators of insect growth; biological pest control; insect resistance
08/04/2005US20050172353 Expression vector for improving heterologous gene expression; herbicide resistant crop plants
08/04/2005US20050172352 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease
08/04/2005US20050172351 Animal model for identifying agents that inhibit or enhance CTLA4 signaling
08/04/2005US20050172350 Identifying modulators of purine/pyrimidine phosphoribosyl transferase (PPPT) polypeptides; treating and preventing microorganismal infection in crop plants
08/04/2005US20050172349 Genetic modification of C57 mice
08/04/2005US20050172348 models can be used to improve diagnosis of diseases relating to energy metabolism as well as identifying and testing pharmaceutical compositions for better treatment and prevention of diseases relating to energy metabolism; transgenic mouse has an elevated glycogen content in skeletal muscle
08/04/2005US20050172347 Using nuclear transformation to generate animal embryo; animal models; uniformity of meat product; animal management
08/04/2005US20050172346 Method for treating a condition with a SOCS-3 promoter linked to a polynucleotide encoding SOCS-3
08/04/2005US20050172345 Recombinant cells comprising muscarinic acetylcholine receptor 6 for use in identifying modulators for prevention and treatment of muscle, eating and nervous system disorders
08/04/2005US20050172343 Astrocyte modulated genes and uses thereof
08/04/2005US20050172342 Production of collagen in the milk of transgenic mammals
08/04/2005US20050171343 Expression of lipoproteins
08/04/2005US20050171339 Method of stabilizing protein
08/04/2005US20050171338 Mammalian tribbles signaling pathways and methods and reagents related thereto
08/04/2005US20050171337 Soluble interleukin-1 receptor accessory molecule
08/04/2005US20050171336 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
08/04/2005US20050171333 Lithium chloride/bromide, alcohol (ethanol/methanol), and trisodium citrate; solid phase synthesis; deoxyribonucleases
08/04/2005US20050171048 Nuclease activity resistance; mixed sequence oligonucleotides containing purine or pyrimidine base in beta anomeric configuration; drug delivery agents; targeting specific DNA and/or RNA sequences
08/04/2005US20050171047 Immunostimulatory nucleic acid molecules
08/04/2005US20050171046 Enhanced secretion / retention of growth hormone releasing hormone (GHRH) from muscle cells by species-specific signal peptide
08/04/2005US20050171044 Oligonucleotide compound and method for treating nidovirus infections
08/04/2005US20050171042 Compositions and their uses directed to binding proteins
08/04/2005US20050171041 Identifying drug targets; assaying for expression of candidate ribonucleic acid in RNAi pathway molecule and svRNA
08/04/2005US20050171040 Chemically synthesized double stranded molecules; hypercholesterolemia, hyperlipidemia, cardiovascular and cerebrovascular disorders, aortic stenosis, peripheral vascular disease, atherosclerosis
08/04/2005US20050171039 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
08/04/2005US20050171018 Novel polypeptide and gene encoding the same
08/04/2005US20050170511 Oxa1p enhanced protein secretion
08/04/2005US20050170510 Using uniform electric charge to transfer vectors into cells; drug delivery; improving exogenous gene expression
08/04/2005US20050170508 For transfecting nucleic acids in vivo or ex vivo; vesicle forming lipid and hydrophilic polymer; gene therapy
08/04/2005US20050170507 Novel lentiviral packaging cells
08/04/2005US20050170505 Formation of polyampholytes in the presence of a polyion
08/04/2005US20050170504 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins
08/04/2005US20050170500 Methods for identifying risk of melanoma and treatments thereof
08/04/2005US20050170496 Method for processing a nucleic acid sample by oscillating a cartridge, a system and a cartridge for performing such a method
08/04/2005US20050170488 Multiply-substituted protease variants
08/04/2005US20050170486 Nucleic acids encoding human inositolpolyphosphate 5-phosphatase
08/04/2005US20050170482 Aerobic succinate production in bacteria
08/04/2005US20050170480 Transgenic microbial polyhydroxyalkanoate producers
08/04/2005US20050170478 Expression of phospholipid:diacylglycerine acyltranssferase (pdat) for the production of plant storage lipids with polyunsaturated fatty acids
08/04/2005US20050170474 Method for producing target substance
08/04/2005US20050170472 Using trangenic gramnegative bacteria exhibiting an overexpression of superoxide dismutase A (SODA) as bioreactor for fermentation of threonine for use in medicine, cosmetics and animal feeds
08/04/2005US20050170469 Hyaluronate synthase gene and uses thereof
08/04/2005US20050170467 Nucleic acid sequences for polypeptides that inhibit endothelial cell growth; PRO Polypeptides; homology to Fibroblast Growth Factor-8 (FGF-8); vectors, host cells, primers and probes
08/04/2005US20050170466 Equine Fc epsilon receptor alpha protein
08/04/2005US20050170463 Recombinant protein production in permanent amniocytic cells that comprise nucleic acid encoding adenovirus E1A and E1B proteins
08/04/2005US20050170462 Methods and host cells for improved cell culture
08/04/2005US20050170461 Identifying modulators which modify ligand protein binding for human pitutary and/or mouse pancreas-derived G protein-coupled receptorl treating nervous system and infectious disorders
08/04/2005US20050170460 Method for diversifying the chemical composition of proteins produced in vivo by genetically disabling the editing function of their aminoacyl tRNA synthetases
08/04/2005US20050170457 Novel recombinant proteins with N-terminal free thiol
08/04/2005US20050170456 Expression vector for improving transcription of bacillus sequences in host cells; bioreactors
08/04/2005US20050170453 Modified promoter
08/04/2005US20050170452 Method to engineer mammanlian-type carbohydrate structures
08/04/2005US20050170451 Human type antihuman ige receptor antibody and fragment
08/04/2005US20050170450 Expression vector for improving transcription of exogenous gene sequences in embryonic kidney cells
08/04/2005US20050170449 Soluble GlcNAc phosphotransferase
1 ... 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 ... 4023